Key Highlights
•
Cushing syndrome, caused by too much cortisol, is often missed because its symptoms are common and its diagnosis is tricky. A new review suggests that tracking a patient’s daily cortisol rhythm, not just single measurements, could be key to better diagnosis and treatment.
Source →
•
A study of over 2,200 patients with cardiac amyloidosis found that nearly 40% had reduced heart pumping function, not just the preserved function it’s known for. This finding is crucial because it means doctors should look for this condition in a wider range of heart failure patients for earlier diagnosis.
Source →
•
A study found that the antiviral drug nirmatrelvir/ritonavir (Paxlovid) is safe and works well in people with severe kidney disease and COVID-19 when given at a lower dose. This is important because these patients are at very high risk from COVID-19 and often can’t take standard antiviral doses.
Source →
•
A large European study shows that lung disease linked to a certain type of autoimmune vasculitis is common and often severe, with a specific scarring pattern seen on scans predicting worse outcomes. The drug rituximab may help slow the decline in lung function for these patients.
Source →
•
A clinical trial successfully created a step-by-step plan for UK hospitals to offer a minimally invasive weight loss procedure called endoscopic sleeve gastroplasty. This provides a practical roadmap to expand treatment options for obesity within the constraints of the public healthcare system.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
